Silverarc Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.3M | Buy |
400,772
+63,167
| +19% | +$3.99M | 4.67% | 5 |
|
|
2025
Q1 | $17.9M | Buy |
337,605
+63,709
| +23% | +$3.37M | 3.66% | 8 |
|
|
2024
Q4 | $15.3M | Buy |
273,896
+18,318
| +7% | +$1.03M | 3.35% | 11 |
|
|
2024
Q3 | $13.4M | Buy |
255,578
+70,916
| +38% | +$3.72M | 3.01% | 8 |
|
|
2024
Q2 | $7.58M | Buy |
184,662
+886
| +0.5% | +$36.4K | 1.79% | 18 |
|
|
2024
Q1 | $7.96M | Buy |
183,776
+9,528
| +5% | +$413K | 2.21% | 14 |
|
|
2023
Q4 | $8.01M | Sell |
174,248
-86,289
| -33% | -$3.97M | 2.38% | 13 |
|
|
2023
Q3 | $5.97M | Buy |
260,537
+144,369
| +124% | +$3.31M | 1.81% | 18 |
|
|
2023
Q2 | $1.92M | Buy |
+116,168
| New | +$1.92M | 0.59% | 43 |
|